KNTPF (Kintor Pharmaceutical) FCF Yield %: -21.62 (As of Jun. 29, 2026)


KNTPF Kintor Pharmaceutical Ltd KNTPF
20 GF Score
Price $0.34
! 3 Warning Signs
View Full Analysis

What is Kintor Pharmaceutical FCF Yield %?

Kintor Pharmaceutical KNTPF 20 FCF Yield % is -21.62 as of Jun. 29, 2026. GuruFocus rates KNTPF with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 1,415 Biotechnology companies, Kintor Pharmaceutical ranks worse than 66.78% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kintor Pharmaceutical's Trailing 12-Month Free Cash Flow is $-24.01 Mil, and Market Cap is $110.65 Mil. Therefore, Kintor Pharmaceutical's FCF Yield % for today is -21.62%.

The historical rank and industry rank for Kintor Pharmaceutical's FCF Yield % or its related term are showing as below:

KNTPF' s FCF Yield % Range Over the Past 10 Years
Min: -462.27   Med: -29.85   Max: -0.52
Current: -21.62


During the past 8 years, the highest FCF Yield % of Kintor Pharmaceutical was -0.52%. The lowest was -462.27%. And the median was -29.85%.

KNTPF's FCF Yield % is ranked worse than
66.78% of 1415 companies
in the Biotechnology industry
Industry Median: -9.62 vs KNTPF: -21.62

Kintor Pharmaceutical's FCF Margin % for the quarter that ended in Dec. 2025 was -374.68%.


Kintor Pharmaceutical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Kintor Pharmaceutical FCF Yield % Related Terms


Kintor Pharmaceutical FCF Yield % Historical Data

* Premium members only.

The historical data trend for Kintor Pharmaceutical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kintor Pharmaceutical FCF Yield % Chart

Kintor Pharmaceutical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial -4.26 -25.56 -73.89 -41.26 -23.90

Kintor Pharmaceutical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.63 -39.03 -36.77 -26.48 -28.05

KNTPF vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Kintor Pharmaceutical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kintor Pharmaceutical FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kintor Pharmaceutical's FCF Yield % falls into.


KNTPF
20GF Score
Kintor Pharmaceutical Ltd KNTPF
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kintor Pharmaceutical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kintor Pharmaceutical's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-24.204 / 101.283264
=-23.90%

Kintor Pharmaceutical's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.204 * 2 / 101.283264
=-28.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -21.62 mean?
Kintor Pharmaceutical (KNTPF) has a FCF Yield % of -21.62 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kintor Pharmaceutical and its competitors. According to the industry distribution chart, Kintor Pharmaceutical ranks #945 out of 1415 companies in the Biotechnology industry, placing it in the top 66.8%.
Is Kintor Pharmaceutical's FCF Yield % too high?
Kintor Pharmaceutical's current FCF Yield % is -21.62. Based on the distribution chart, Kintor Pharmaceutical ranks #945 out of 1415 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Kintor Pharmaceutical has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Kintor Pharmaceutical's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kintor Pharmaceutical ranks #945 out of 1415 companies for FCF Yield %. This places Kintor Pharmaceutical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kintor Pharmaceutical and its competitors. Kintor Pharmaceutical's current FCF Yield % is -21.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kintor Pharmaceutical stock overvalued right now?
Kintor Pharmaceutical (KNTPF) has a current FCF Yield % of -21.62. The current FCF Yield % is -21.62. Kintor Pharmaceutical's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Kintor Pharmaceutical (KNTPF), the current FCF Yield % is -21.62 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kintor Pharmaceutical Business Description

Other Exchanges 09939:Hong Kong
Address No. 20 Songbei Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215123
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China, focusing on developing therapeutic drugs for unmet medical needs. Its pipelines cover indications of dermatology, such as AGA and acne vulgaris, and indications of tumors, catering to the unmet medical needs of patients and cosmetics consumers globally. The Group's cosmetic product types include anti-hair loss, acne treatment, and skin whitening products. Kintor's pipeline consists of various drug candidates such as KX-826, AR-PROTAC Compound (GT20029), GT1708F (Hedgehog/SMO Inhibitor), GT0486, and ALK-1 Antibody (GT90001). It has only one reportable operating segment, which is engaged in the research and development of medicine products and extends to functional cosmetics and raw materials.
20GF Score

Get the complete analysis for KNTPF

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price